在癌症和癌症之外的CHD1L:结构,瘤功能和治疗潜力
Sophia Clune1, Paul Awolade1,2, Hector Esquer1,2,3
1Skaggs School of Pharmacy and Pharmaceutical Sciences, Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
概括
染色体酶DNA结合蛋白1-Like (CHD1L) 是一种致癌因素,驱动瘤进展,转移和治疗抵抗. 向CHD1L为各种固体瘤提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 染色体酶DNA结合蛋白1-Like (CHD1L) 被认为是一种致癌因素.
- CHD1L促进瘤的进展,转移,以及对治疗的抗性.
- 它的过度表达与固体瘤的不良预后有关.
研究的目的:
- 审查CHD1L的结构,致癌功能和发育起源.
- 突出针对CHD1L的新兴治疗策略.
- 了解CHD1L在癌症生存和免疫逃避中的作用.
主要方法:
- 关于CHD1L在癌症中的作用的文献综述.
- 对CHD1L参与转录程序,DNA损伤反应和细胞死亡途径的分析.
- 检查CHD1L对关键生存蛋白 (SPOCK1,MDM2,TCTP) 的调节.
主要成果:
- CHD1L驱动上皮层-介质酶过渡 (EMT),细胞骨重塑和转移.
- CHD1L调节DNA损伤反应,修复和细胞周期进展,增强瘤细胞的存活率.
- CHD1L抑制了包括PARthanatos在内的亡和非亡细胞死亡,并有助于免疫逃避.
结论:
- CHD1L是一种关键的瘤原因子,在癌症进展,生存和免疫规避方面具有多方面的作用.
- 向CHD1L代表了开发新型癌症疗法的可用药物脆弱性.
- 对CHD1L的机制和治疗向的进一步研究是有必要的.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
11.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.2K
Cancer
53.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
Structure of Cadherins
4.7K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
4.7K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K


